Healthcare • Biotechnology
EODHD (TTM) · as of Nov 6, 2026
End-of-day close from stored market data, not a live quote.
Celularity Inc., a cellular and regenerative medicine company, focuses on addressing aging-related disease using novel therapies. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It develops off-the-shelf placental-derived allogeneic cell therapy product candidates, including mesenchymal-like adherent stromal cells for diabetic foot ulcer and Crohn's disease.
Its therapeutic programs include PDA-001 for the treatment of autoimmune (Crohn's) and degenerative disease; and PDA-002 for treating multiple sclerosis, rheumatoid arthritis, stroke, and diabetic peripheral neuropathy. The company also produces, sells, and licenses products used in surgical and wound care markets, such as Biovance, Biovance 3L, Rebound, Interfyl, and Centaflex; and collects, processes, and stores umbilical cord and placental blood and tissue after full-term pregnancies under the LifebankUSA brand. Celularity Inc. has licensing agreement with Sorrento Therapeutics, Inc. for the development and commercialization of licensed CD19 CAR-T products; and research collaboration services agreement with Regeneron Pharmaceuticals, Inc. to support the research of allogeneic cell therapy candidates. Celularity Inc. was founded in 1998 and is headquartered in Florham Park, New Jersey.
Company profile from EODHD, stored Oct 30, 2026.
The last 8 fiscal quarters as reported (EODHD). Year over year compares the same quarter a year earlier.
| Quarter | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Sep 2026filed Oct 20, 2026 | $5.4M | +2.8% | 56.8% | -$4.2M | $706.0K |
| Jun 2026filed Sep 29, 2026 | $3.8M | -32.9% | 62.2% | -$10.1M | $874.0K |
| Mar 2026filed Apr 30, 2026 | $4.1M | -77.4% | -79.7% | -$22.1M | -$24.4M |
| Dec 2025 | $4.1M | -77.4% | -79.7% | -$22.1M | -$24.4M |
| Sep 2025filed Nov 14, 2025 | $5.3M | -43.2% | 26.1% | -$12.9M | -$23.1M |
| Jun 2025filed Aug 29, 2025 | $5.7M | -52.6% | 8.6% | -$15.9M | -$24.5M |
| Mar 2025filed May 8, 2025 | $18.1M | +23.5% | 59.5% | -$9.3M | -$13.3M |
| Dec 2024 | $18.1M | +378.9% | 59.5% | -$9.5M | -$13.3M |
| Fiscal year | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Dec 2025filed Apr 30, 2026 | $26.6M | -51.0% | 24.4% | -$61.3M | -$91.8M |
| Dec 2024filed May 8, 2025 | $54.2M | — | 72.4% | -$38.4M | -$57.9M |
| Dec 2022filed Mar 31, 2023 | $18.0M | -15.7% | -9.4% | -$25.6M | $14.2M |
| Dec 2021filed Mar 31, 2022 | $21.3M | +49.4% | 54.8% | -$109.1M | -$100.1M |
| Dec 2020filed Mar 4, 2021 | $14.3M | -32.5% | 65.5% | -$151.9M | -$208.2M |
| Dec 2019filed Mar 24, 2020 | $21.1M | +20.5% | 70.1% | -$264.1M | -$211.9M |
FINRA reports open short positions for a settlement date. The publication date is later. These are reported positions, with a separate date for each observation.
Compare the reported short exposure around the dates you bought, sold or watched CELU. A long position benefits from price rises; a short position benefits from falls. A change in these counts does not predict either move.
Settlement Oct 15, 2026
441,798 shares short
+50,522 shares (+12.9%) vs Sep 30, 2026
2% of the stored float. Published Oct 26, 2026.
Settlement Sep 30, 2026
391,276 shares short
-429,744 shares (-52.3%) vs Sep 15, 2026
2.1% of the stored float. Published Oct 9, 2026.
Settlement Sep 15, 2026
821,020 shares short
-1,076,702 shares (-56.7%) vs Aug 31, 2026
4.4% of the stored float. Published Sep 24, 2026.
Settlement Aug 31, 2026
1,897,722 shares short
+1,494,154 shares (+370.2%) vs Aug 14, 2026
10.1% of the stored float. Published Sep 10, 2026.
Settlement Aug 14, 2026
403,568 shares short
+12,732 shares (+3.3%) vs Jul 31, 2026
Share of float unavailable. Published Aug 25, 2026.
Settlement Jul 31, 2026
390,836 shares short
-28,697 shares (-6.8%) vs Jul 15, 2026
Share of float unavailable. Published Aug 11, 2026.
Change = this settlement’s shares short − the previous recorded settlement’s shares short; percentage change divides by that earlier count. A zero earlier count has no percentage change. Split-spanning counts are left uncompared. Float percentages use the stored settlement observation, not today’s float.
Source: stored FINRA equity short-interest records, up to six settlements from the last 240 days. FINRA data and reporting dates · How to read short interest
See the recorded cash amounts and dates behind CELU’s income, and the splits that change its share count. Dates below are stored event records, not confirmation of a payment to your account.
No qualified cash-dividend records are stored. This does not establish that the company pays no dividend.
Up to six Polygon cash-dividend events, including recorded ex-dates within the next 120 days. Amounts retain their recorded currency and decimal precision. Historical amounts are not restated to a common split basis, annualized, or converted to dollars.
For a long holding, compare the ex-date with when you held the shares and check the pay date against your broker’s cash history. Owning the stock today does not establish past entitlement. For a short holding, a dividend can create a payment obligation to the share lender.
Ex-dates and special dividend rules · Short-sale dividend obligations · Dividend data definitions
1 for 10 · reverse split
Effective Feb 29, 2024
Each 10 pre-split shares become 1 post-split share.
Source: EODHD
Up to six stored split dates through Nov 7, 2026. Equivalent vendor ratios are combined; conflicting ratios are left out. This history may be incomplete.
A split changes the share count and per-share price basis; it does not by itself add investment value. Put your holding’s earlier and later share counts on the same basis before comparing them. This applies to both long shares and shares owed on a short position.
How stock splits workSign in to see your position size
We’ll show you if CELU is in your portfolio and how much it contributes.
Sign inLoading market dates
8 smart-money holders: institutions with a high Holder IQ
Sentiment: unknown
No recent insider trades detected.
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
No directional recent-activity label is available. This context label is separate from the scored insider signal read.
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Red flags: 4
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
No directional recent-activity label is available. This context label is separate from the scored insider signal read.
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
40 filers reported a long position in CELU for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
The top 10 hold
90.6%
of the 2.2M shares 13-F filers reported
Moves vs Q1 2026
1 added2 trimmed
1 new · 6 unchanged
Net shares held
-1.6%
across the 9 holders with a comparable Q1 2026 book
| Rank | Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|---|
| 1 | C V STARR & CO INC | $1.6M · 764.1K shares | 764.1K | Unchanged |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | $371.4K · 621.1K shares | 621.1K | Unchanged |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | $100K · 167.2K shares | 167.2K | -12.5% |
| 4 | CITADEL ADVISORS LLC | $59.2K · 99.1K shares | 99.1K | New |
| 5 | VANGUARD FIDUCIARY TRUST CO | $47.8K · 79.9K shares | 79.9K | Unchanged |
| 6 | BlackRock, Inc. | $45.7K · 76.4K shares | 76.4K | -40.1% |
| 7 | STATE STREET CORP | $34.6K · 57.8K shares | 57.8K | Unchanged |
| 8 | HRT FINANCIAL LP | $33K · 56.6K shares | 56.6K | +342.7% |
| 9 | NORTHERN TRUST CORP | $26.4K · 44.2K shares | 44.2K | Unchanged |
| 10 | Biltmore Family Office, LLC | $20.9K · 35K shares | 35K | Unchanged |
Sign in to see each holder’s Holder IQ, factor-adjusted Holder IQ and rank, and compare these holders with all scored filers. Available on every plan.
Sign inHolders of more than 5% of CELU file with the SEC within days. A 13D holder may seek to influence the company; a 13G holder is passive. Each holder’s latest filing from the last three years.
| Filed | Holder | % of class |
|---|---|---|
| Sep 28, 2026 | Philip & Daniele Barach Family Trust13D · activist · amended | 29% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.